Skip to content

Honey to Improve Sleep Quality

Poor Quality Sleep

Inadequate sleep quality and duration affects quality of life, and can cause adverse health outcomes, for many Canadians. Existing sleep therapies have limitations, such as inability to adhere to a cognitive behaviour modification or the risk of dependence on pharmaceutical therapies. Raw honey has a long history of anecdotal reports supporting its use to improve sleep quality. In an effort to develop an evidence base for honey as a sleep aid, we completed a preliminary proof-of-principle study to assess feasibility and potential effectiveness of honey to improve sleep quality. Results of our preliminary study demonstrate that honey is safe and effective for improving quality of sleep with no associated adverse effects, as compared to melatonin. The current study design builds off the experiences of the preliminary trial and will add more scientific rigor to the evidence base we have started to build.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 to 55

Critères de participation

Inclusion Criteria:

* Aged 18 - 55yrs
* Male or female
* Able to comply with study protocol and give informed consent
* Healthy (no diagnosis of medical or mental illness and not suffering from vascular disease, diabetes mellitus, hyperlipidemia, obesity \[body mass index over 30\], dermatological disease, gynecological disease, endocrine disease)
* Discontinuation of sleep aids 4 weeks in advance of the study
* Self-report of having difficulty sleeping for 1 week or more

Exclusion Criteria:

* Age: \<18 and \>55
* Type I and Type II diabetes, current infectious disease (e.g. cold or flu)
* Unstable medical condition
* History of psychiatric disorder (past or present)
* Pain syndrome affecting sleep
* Obese (BMI over 30)
* Pregnant or lactating women
* Lifestyle habits that would modify the wake-sleep rhythm (e.g. night work; shift work; young children that interrupt sleep)
* Substance and/or drug dependence (alcohol, nicotine, pain killers)
* Use of the following medications during the study period: oral or injectable corticosteroid, sedating antihistamines (e.g. cold, allergy, motion sickness), psychotropic medications or hypnotics, benzodiazepine, narcotics, any illicit drugs
* Use of stimulants (\>4 cups \[1 cup = 250 mL\] of coffee/day)
* Participation in any other clinical trial with an investigational agent within one month prior to randomization

Lieu de l'étude

University of Saskatchewan
University of Saskatchewan
Saskatoon, Saskatchewan
Canada

Contactez l'équipe d'étude

Primary Contact

Whitney Duff, PhD

[email protected]
3067172217
Backup Contact

Stephanie Vuong, MSc

[email protected]
3063701983
Étude parrainée par
University of Saskatchewan
Participants recherchés
Plus d'informations
ID de l'étude: NCT04207281